By
Drug Target Review2025-06-23T08:30:14
DenovAI has unveiled a powerful AI-driven protein design platform capable of creating new, functional synthetic proteins from scratch - marking a big step forward for drug discovery.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-01-06T16:37:30
Sponsored by Catalent
2023-11-20T13:43:43
Sponsored by Merck
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2026-06-24T13:00:00 2026-06-24T14:00:00
Sponsored by HUB Organoids
2023-07-03T10:28:23
Sponsored by Merck
Site powered by Webvision Cloud